Literature DB >> 1730219

Glycosylation of interleukin-6 purified from normal human blood mononuclear cells.

R B Parekh1, R A Dwek, T W Rademacher, G Opdenakker, J Van Damme.   

Abstract

Interleukin 6 (IL-6) is a glycosylated cytokine which is important in exerting cell-specific growth-inducing, growth-inhibiting and differentiation-inducing effects. IL-6 produced in mammalian cell lines is heterogeneous, reflecting specific cell-type-dependent post-translational modifications. Native IL-6 was purified from human blood mononuclear cells and the oligosaccharides released, radiolabelled and sequenced by a combination of sequential exoglycosidase digestion using Bio-Gel P-4 high-resolution gel chromatography and acetolysis. N- and O-linked glycans were found. The N-linked glycans were sialylated di- and tri-antennary complex-type and oligomannose-type structures. However, the most predominant N-linked oligosaccharide was a small tetrasaccharide with the sequence Man alpha 6Man beta 4GlcNAc beta 4GlcNAc. This is the first report of this structure on a circulating glycoprotein. This structure has only previously been reported to be present on the syncytiotrophoblast of human placenta. The presence of the oligomannose structures and the mannose-terminating tetrasaccharide on IL-6 may be important in maintaining a high local concentration of the cytokine while limiting its systemic serum level via interaction with soluble mannose-binding serum lectins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730219     DOI: 10.1111/j.1432-1033.1992.tb19838.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Human herpesvirus 8-encoded cytokines.

Authors:  John Nicholas
Journal:  Future Virol       Date:  2010-03       Impact factor: 1.831

2.  Fast sequencing of oligosaccharides: the reagent-array analysis method.

Authors:  C J Edge; T W Rademacher; M R Wormald; R B Parekh; T D Butters; D R Wing; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

3.  Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.

Authors:  Abida Zahirović; Aleš Berlec
Journal:  Microb Cell Fact       Date:  2022-07-16       Impact factor: 6.352

4.  Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.

Authors:  Zhiqun Tang; Rency S Varghese; Slavka Bekesova; Christopher A Loffredo; Mohamed Abdul Hamid; Zuzana Kyselova; Yehia Mechref; Milos V Novotny; Radoslav Goldman; Habtom W Ressom
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

Review 5.  Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor.

Authors:  Cate Moriasi; Dharmalingam Subramaniam; Shanjana Awasthi; Satish Ramalingam; Shrikant Anant
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

6.  Natural Glycoforms of Human Interleukin 6 Show Atypical Plasma Clearance.

Authors:  Andreas Reif; Kevin Lam; Sascha Weidler; Marie Lott; Irene Boos; Juliane Lokau; Christian Bretscher; Manuel Mönnich; Lukas Perkams; Marina Schmälzlein; Christopher Graf; Jan-Patrick Fischer; Carolin Lechner; Kerstin Hallstein; Stefan Becker; Michael Weyand; Clemens Steegborn; Gerhard Schultheiss; Stefan Rose-John; Christoph Garbers; Carlo Unverzagt
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-06       Impact factor: 15.336

Review 7.  The Tn antigen-structural simplicity and biological complexity.

Authors:  Tongzhong Ju; Vivianne I Otto; Richard D Cummings
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-21       Impact factor: 15.336

8.  Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein.

Authors:  A R Neurath; N Strick; Y Y Li
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.